Amir Ansaripour

Suggest Changes

Writes About:

Learn More
We welcome the comments on our article ‘‘Adjuvant trastuzumab therapy for early HER2-positive breast cancer in Iran: a cost-effectiveness and scenario analysis for an optimal treatment strategy’’ [1](More)
  • 1